Coulter Partners is a board and senior level global executive search specialist focused exclusively on Life Sciences. We work closely with those at the cutting edge of innovation in the industry to understand their challenges. With an extensive global network and expertise gained over 25 years in the sector, we have become trusted advisers on leadership in the pharmaceuticals, biotechnology, medical technology, diagnostics, health tech, CRO and services sectors. We also work closely with the global investor community, hiring for their own teams as well as building the boards and executive leadership teams of their portfolio companies. The largest and fastest growing dedicated Life Science search firm, our team of 95 completes over 260 assignments a year working from 14 offices across UK, EMEA, USA & APAC. We share knowledge and connections across the globe, as one team with one goal. To bring our clients the world’s best talent.
At the heart of everything they do Coulter Partners is an exceptional team of talented individuals. Multi-disciplined, passionate and committed to being the best, they have PhDs, MBAs and speak many languages. Every challenge is approached with a blend of innovative thinking and best-in-class search methodology. There are no barriers to sharing information and everyone is rewarded for quality delivery. Exchanging knowledge, experience and data brings mutual support. Success follows naturally.
Coulter Partners is a global search specialist focused exclusively on life sciences. The firm is held in the highest regard as trusted adviser to the sector on senior leadership roles in the American, U.K. and European Markets.
Over the past few months, numerous healthcare organizations have turned to executive search firms to find new chief medical officers. In the era of COVID-19 this is likely to be another burgeoning area for executive search firms. Life sciences search specialist Coulter Partners recently partnered with Memo Therapeutics AG for the recruitment of George Badita as its new
Life sciences search specialist Coulter Partners recently partnered with 2N Pharma, a biotech company developing therapeutic drugs to treat neurological disorders, to secure the appointments of Alex Leech as chair of the board of directors and John Kemp as non-executive director. “We are very proud and excited to welcome Alex and John to the board,” said Preben Bruun-Nyzell,
Life sciences search specialist Coulter Partners has placed Francisco Salva as president and CEO of Azitra Inc. in Branford, CT. He replaces Rick Andrews who is retiring. Client partner Chris Palatucci led the assignment. “We are excited to bring in Francisco’s remarkable experience and leadership,” said Travis Whitfill, co-founder, executive director of advanced technology and chair, scientific
Life sciences search specialist Coulter Partners has placed Walter Miller as chief finance officer and Charles Woler as non-executive director of Optimapharm. Directors Mark Sharp and Irene Montgomery led the assignment. “It has been a privilege to partner with Optimapharm on two more key search assignments, following our collaboration to bring Andrew Copestake on board as CEO
(July 2021) Coulter Partners was very pleased to partner recently with Memo Therapeutics AG, an innovator in the field of antibody discovery and development, to secure the appointment of Dr. George Badita as Chief Medical Officer. Dr. Badita is an MD, board certified in Infectious Diseases, with over 30 years of experience in life sciences
(July 13, 2021) Coulter Partners was very pleased to partner recently with Memo Therapeutics AG, an innovator in the field of antibody discovery and development, to secure the appointment of Dr. George Badita as Chief Medical Officer. Dr. Badita is an MD, board certified in Infectious Diseases, with over 30 years of experience in life
(April 2021) Coulter Partners was very pleased to partner recently with OxSonics® Therapeutics, a world leader in the development of ultrasound-based drug delivery systems for the treatment of cancer, to secure the appointment of Dr Allison Jeynes as non-executive Chair of the Board of Directors. Dr Allison Jeynes, MD, FFPM (UK), is a trained clinician
(March 2021) Global Life Sciences executive search specialist, Coulter Partners is delighted to announce continuing growth across the company in 2021. The London team expands with new Associates, Lucy Webb and Ana Delgado, Research Analysts, Jacob Taylor and Liam Fryer, and Director, Carina McEntire. In the US, Ayn Teigman is appointed Associate in New York
(March 1, 2021) Coulter Partners was delighted to partner again recently with Optimapharm to secure the appointments of Walter Miller as Chief Finance Officer and Dr Charles Woler, M.D., Ph.D., as Non-Executive Director. Optimapharm is a contract research organization (CRO) managing clinical trials on behalf of leading biotech, pharma and medical devices companies in 27